MBD5

methyl-CpG binding domain protein 5, the group of Methyl-CpG binding domain containing|PWWP domain containing

Basic information

Region (hg38): 2:148021011-148516971

Links

ENSG00000204406OMIM:611472HGNC:20444Uniprot:Q9P267AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant non-syndromic intellectual disability (Supportive), mode of inheritance: AD
  • intellectual disability, autosomal dominant 1 (Strong), mode of inheritance: AD
  • complex neurodevelopmental disorder (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder, autosomal dominant 1ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Neurologic; Ophthalmologic17847001; 21981781

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MBD5 gene.

  • Intellectual disability, autosomal dominant 1 (52 variants)
  • not provided (17 variants)
  • Inborn genetic diseases (4 variants)
  • Intellectual disability (2 variants)
  • Autism spectrum disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MBD5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
305
clinvar
5
clinvar
316
missense
3
clinvar
641
clinvar
126
clinvar
10
clinvar
780
nonsense
24
clinvar
9
clinvar
1
clinvar
34
start loss
1
clinvar
1
frameshift
41
clinvar
10
clinvar
4
clinvar
55
inframe indel
12
clinvar
2
clinvar
14
splice donor/acceptor (+/-2bp)
3
clinvar
2
clinvar
1
clinvar
6
splice region
1
9
16
5
31
non coding
4
clinvar
57
clinvar
21
clinvar
82
Total 68 25 669 490 36

Variants in MBD5

This is a list of pathogenic ClinVar variants found in the MBD5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-148021034-A-G not specified Likely benign (Sep 29, 2016)381693
2-148021035-G-A not specified Likely benign (Feb 10, 2017)517739
2-148021062-C-T not specified Likely benign (Oct 16, 2015)381112
2-148021483-GCTGCTGCTGCTGCTA-G Likely benign (Feb 01, 2024)2651402
2-148021483-G-GCTGCTGCTGCTGCTA Likely benign (Dec 01, 2023)2651401
2-148021496-C-CTGT Likely benign (May 01, 2024)2651403
2-148021676-G-A Likely benign (Feb 21, 2019)378113
2-148021702-G-A not specified Likely benign (Jun 06, 2016)386656
2-148178611-A-C Benign (Jun 23, 2018)1262738
2-148178697-T-C Likely benign (May 02, 2018)682419
2-148178801-G-GT Intellectual Disability, Dominant • not specified Conflicting classifications of pathogenicity (Nov 01, 2022)206049
2-148233246-A-G Benign (Mar 03, 2015)1265319
2-148233249-A-G not specified Likely benign (Aug 02, 2017)511202
2-148233382-A-G not specified Likely benign (Oct 28, 2016)390534
2-148342230-C-T not specified Likely benign (Sep 01, 2017)331321
2-148342233-A-C not specified Likely benign (Jan 23, 2017)507022
2-148342233-A-T Benign (Mar 03, 2015)1273852
2-148342300-C-CA Intellectual Disability, Dominant Uncertain significance (Jun 14, 2016)331323
2-148342342-C-A not specified Likely benign (Sep 07, 2017)511860
2-148342440-G-A Likely benign (Feb 08, 2022)1700716
2-148342533-A-T Benign (Jun 23, 2018)1243796
2-148342583-T-C Benign (Jun 23, 2018)1295206
2-148458195-T-C not specified Benign (Aug 01, 2024)138171
2-148458759-A-G Intellectual disability, autosomal dominant 1 Likely pathogenic (Oct 25, 2018)813806
2-148458766-G-T Intellectual disability, autosomal dominant 1 Uncertain significance (Oct 25, 2022)198229

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MBD5protein_codingprotein_codingENST00000407073 10497226
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.00000141125742041257460.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8567107770.9140.00004039822
Missense in Polyphen3542.0730.83188419
Synonymous-0.6113012881.050.00001613033
Loss of Function6.04246.40.04310.00000244595

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002640.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds to heterochromatin. Does not interact with either methylated or unmethylated DNA (in vitro).;
Disease
DISEASE: Mental retardation, autosomal dominant 1 (MRD1) [MIM:156200]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:17847001, ECO:0000269|PubMed:22726846}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Post-translational protein modification;Metabolism of proteins;UCH proteinases;Deubiquitination (Consensus)

Recessive Scores

pRec
0.0958

Intolerance Scores

loftool
0.0116
rvis_EVS
-2.12
rvis_percentile_EVS
1.52

Haploinsufficiency Scores

pHI
0.522
hipred
Y
hipred_score
0.520
ghis
0.605

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.936

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mbd5
Phenotype
craniofacial phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
nervous system development;protein deubiquitination;regulation of multicellular organism growth;glucose homeostasis;regulation of behavior;positive regulation of growth hormone receptor signaling pathway
Cellular component
nucleus;nucleoplasm;chromocenter;midbody;extracellular exosome
Molecular function
DNA binding;chromatin binding